Total Funding
85
67
Total FundingSeed raised
Growth Score 85 in past quarter
-4 pts
Heat Score 67 in past quarter
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
139562
Cura Therapeutics develops immunotherapies to cure cancer and infectious diseases.
- Claudia A. Penafuerte Diaz: Co-Founder and CEO
About the Company
Cura Therapeutics is actively seeking strategic partnering opportunities and collaborations with pharmaceutical and biotechnology companies to develop and commercialize cancer immunotherapies based on multifunctional fusion proteins. Their immunotherapy can be used alone or in combination with a wide range of targeted therapies or cell-based
therapies such as immune checkpoint inhibitors and CART therapies.